Drug Manufacturers - Specialty & Generic | Healthcare
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dosage forms, such as tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, cold rubs, eye drops, troches, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners; and contract manufacturing services. The company provides its products in gastroenterology, anti-infectives, wound care, neonatology and pediatrics, gynaecology, dental, vitamins and minerals, hypertension, diabetes, nephrology, respiratory, pain-analgesic, dermatology, antivirals, lozenges, and contrast media and radio diagnostic therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Mumbai, India.
Market Cap
266343497728
Current Price
1698.5
52 Week Range
1385.75 - 2030.0
Previous Close
1667.8
Open
1678.6
Sector
Healthcare
Address
Cnergy IT Park, Unit A2, 3rd floor, Unit A, 8th floor Appa Saheb Marathe Marg Prabhadevi, Mumbai, 400025, India
Phone
+91-22243-95200
Fax
+91-22243-15331
Website
https://www.jbpharma.com
Day Low
1671.0
Day High
1708.0
Dividend Yield
1.01
PE Ratio
41.066246
Earnings Per Share
41.36
Beta
-0.089
EBITDA
10318399488
Book Value
220.577
EPS
51.43077
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Nikhil Ashokkumar Chopra | CEO & Whole-Time Director | 51 | 1973 |
Suresh Amin | Assistant Vice President Human Resource | - | - |
Mr. Narayan Saraf | Chief Financial Officer | 44 | 1980 |
Mr. Kunal Khanna | President of Operations | 44 | 1980 |
Mr. Bhagwat Singh Deora | Vice President of Finance & Accounts | 42 | 1982 |
Mr. Suresh Bhise | Vice President of Information & Technology | 58 | 1966 |
Mr. Sridhar Bharadwaj | Vice President of HR & Administration | 57 | 1967 |
Mr. Himanshu Ranvah | Vice President of Legal | 39 | 1985 |
Mr. Pradeep Kumar Singh | President of Global Business | 60 | 1964 |
Mr. Parmeshwar B. Bang | Executive Vice President of Operations of Daman | 56 | 1968 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.